Who is sponsoring NCT06696339?

NCT06696339 is sponsored by PreemptiveAI, Inc.

What drugs are being tested in NCT06696339?

Interventions in NCT06696339: PreemptiveAI SDK.

What condition does NCT06696339 study?

NCT06696339 studies Heart Rate in the General Public.

Is NCT06696339 still recruiting?

NCT06696339 is currently active, enrolled. Last updated 20 November 2024.

Last reviewed 2024-11-20 · How we verify

NCT06696339

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults

Active, enrolled Last updated 20 November 2024

What this trial tests

trial testing PreemptiveAI SDK in Heart Rate in the General Public in 100 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

3 October 2024

Primary endpoint
15 November 2024

1 March 2025

Quick facts

Lead sponsor	PreemptiveAI, Inc
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	100
Start date	3 October 2024
Primary completion	15 November 2024
Estimated completion	1 March 2025
Sites	1 location across United States

Drugs / interventions tested

PreemptiveAI SDK

Conditions studied

Heart Rate in the General Public — all drugs for Heart Rate in the General Public →

Sponsor

PreemptiveAI, Inc

Who can join

18 and older, any sex, with Heart Rate in the General Public. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to assess the accuracy of the PreemptiveAI SDK to measure heart rate for adults as compared to an FDA-approved ground truth device. Participants will: * Complete a demographics and health history survey * Apply and wear ground truth equipment such as a pulse oximeter and ECG * Measure their heart rate 8 times with 4 different smartphones using the PreemptiveAI SDK

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06696339 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PreemptiveAI, Inc
Last refreshed: 20 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06696339.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing